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Chromoblastomycosis is a chronic mycosis infection of the skin and subcutaneous tissue. The lesson 
begins with a history of trauma characterized by slowly gradual growing nodule lesions, especially in 
the lower extremities. Management of chromoblastomycosis may be physical and non-physical and 
combination to achieve the best result. A 70-year-old male farmer came with a rough lump on his left 
leg in the past six years ago. Lesions were multiple-verrucous, varying sizes nodules on the left limb. 
Skin scraps examination showed copper penny appearance or Medlar bodies. Histopathological 
examination showed granulomatous inflammation and Medlar bodies. In fungi culture, we obtained 
Fonsecaea pedrosoi. Patients were treated with a combination of Itraconazole 400 mg/day for a week 
for three months (pulse dose) and serial cryosurgery once per week. The combination therapy gave 
clinical improvement and good results. The diagnosis of chromoblastomycosis is based on history, 
physical examination, histopathology, and culture. Predisposing factors are working in the fields in 
this case and being exposed to trauma such as soil and plants. Giving combination therapy with 
itraconazole and cryosurgery makes good results for this patient. 
 




Chromoblastomycosis is a chronic 
profound fungal infection on skin and 
subcutaneous tissue, characterized by papular 
lesions, plaque, and verrucous nodules that 
are slowly growing. Medlar body can be 
found on skin scraping. Histopathological 
examination showed Medlar body from 
tissue, particularly affecting leg and leg. 
Chromoblastomycosis is rarely found.1  
The aetiology of chromoblastomycosis 
is dark-pigmented fungi / dermaticeae fungi / 
black fungi, including Fonsecaea pedrosoi, 
Fonsecaea compactum, Wangiella dermatitis, 
and Cladophialophora carrionii.1 
Chromoblastomycosis can result from 
environments such as wood, plant, and soil. 
Primary inoculation can occur through 
network trauma, with predilection on lower 
extremities generally.2,3 
Chromoblastomycosis is found in 
tropical and subtropical states like America, 
Africa, Australia, and India. Japan has the 
highest chromoblastomycosis incidence 
among 1,416,000 Asian populations.3 Two 
chromoblastomycosis cases were reported by 
Sansan et al. in the Dermatology Clinic of   
Dr. Moewardi Hospital Surakarta between 
2010-2011.4 The prevalence is higher in male 
adults than in women and children, and it is 
often attributed to patients’ occupation.5 More 
than half of the cases occur in adults aged 30-
60 years. Patient’s occupation is generally 
related to soil, tending to develop trauma, 
such as farmer, gardener, wood seeker in the 
jungle, labour of animal husbandry, etc. 1,2  
Chromoblastomycosis is a variable 
clinical presentation. Generally, the primary 
lesion is warty papule accompanied with 
slowly developing squamous tissue and then 
progressively changing into polymorph 
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constituting nodule, tumour, verrucous, 
plaque, or cicatrix.2,5 
Work up is conducted with KOH 10% 
of infected skin tissue, indicating oval or 
spherical single and colony spore fungi 
fragment, with thick wall and blackish-brown 
colour.6 Macroscopic examination on fungus 
culture finds bright brown filament colony 
and brown sclerotic/medlar body, while 
microscopic observation finds long 
partitioned hypha with ramification conidia. 
Histopathological examination reveals 
pseudoepitheliomatous epidermal hyperplasia 
and broad dermal infiltrates consisting of 
epithelioid histiocyte cells rather than 
neutrophil and lymphocyte cells. Thick-
walled spore seems to be round or oval-
shaped blackish-brown that can be single or in 
the colony, called copper penny appearance or 
Medlar body.2-7 
Patients with chromoblastomycosis  are 
still a true therapeutic challenge for clinicians 
due to the recalcitrant nature of the disease, 
especially in the severe clinical forms.3 Oral 
itraconazole (pulse dose) 200-400 mg/day 
shown clinical and mycological cure after 
10.9 months on 30 Brazilian people. A 
reported study of cryosurgery with 
itraconazole with 22 cases achieved a 
mycological and clinical cure rate of 40.9%, 
so they are currently being the best 
combination.3 This paper reports a 
chromoblastomycosis case in a 70-year old 
man who had the disease for six years. He also 
got clinical improvement with combined 




A 70-year male farmer who lived in 
Semarang, Central Java, came to the 
Dermatovenereology Department of               
Dr. Moewardi Hospital, Surakarta, with a 
chief complaint of a lump on the left leg. The 
patient said that it had begun 6 (six) years ago. 
One month ago, he had sought some 
clinicians, but the complaint did not improve.  
The patient had no history of chronic 
cough, food allergy, asthma, diabetes 
mellitus, or hypertension. The family history 
was also denied.   
From the physical examination, we 
found well general condition, compos mentis 
awareness, and vital signs are normal. In 
dermatological examination on the left ankle 
region, we found multiple hyperpigmented 
nodules with the verrucous surface (Figure 1). 
We could propose the differential diagnoses 
of the case were chromoblastomycosis and 
squamous cell carcinoma taken from the 
history and physical examination.  
The routine blood laboratory was within 
normal limits. X-ray imaging showed a 
normal result. KOH 10% examination on the 
tissue indicated oval, spherical single and 
colony spores, discovered thick wall and 
blackish-brown colour appearance leading to 
chromoblastomycosis (Figure 2). Biopsy was 
conducted on this patient by taking skin tissue 
on the left ankle region, in 1.5 cm size, with 
brown colour. Then, histopathological 
examination was performed using 
hematoxylin-eosin (HE) staining, obtaining 
granulomatous inflammation, and 
pseudoepitheliomatous hyperplasia was 
found in 10x magnification. The 40x 
magnification revealed inflammatory cell 
infiltration and Medlar body / Copper penny 
representation. The 100x magnification 
indicates Medlar body/copper penny and no 
malignancy sign (Figure 3. A-C). Periodic 
acid shift (PAS) staining with 40x and 100x 
magnifications indicated pale-colour spores 
(positive PAS) with the conclusion supporting 
chromoblastomycosis (Figure 3. D-E).     
The examination of fungi culture using 
Sabouraud Dextrose Agar (SDA) 
macroscopically reveals a brown filament 
colony. The culture slide microscopically 
indicated long branching filamentous hypha 
with conidia, consistent with Fonsecaea 
pedrosoi (Figure 4). Considering anamnesis, 
physical examination, and supporting 
examination, this patient was diagnosed with 
chromoblastomycosis. The patient underwent 
oral itraconazole 400 mg/day therapy within a 
week for three months (pulse dose) and 1-
cycle / week cryotherapy with a minute 
duration (Figure 5,6,7). The patient’s lesion 
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seemed to improve following cryotherapy and 
itraconazole therapy (pulse dose) processes. 
KOH 10% examination showed no spore 
(Figure 8).   
 
 
                
Figure 1. (A-C) Local state of left ankle region showed multiple hyperpigmented nodules with 
verrucous a surface. 
 
                            
 
Figure 2. Microscopic result of 10% KOH taken from infected skin scraping on verrucous nodule 
lesion (A, B, C) indicating Medlar body/copper penny. 
 
            
        
Figure 3. (A). 10x magnification with HE;(B). 40x magnification with HE; (C). 100x 
magnification with HE; (D). 40x magnification with PAS; (E). 100x magnification with PAS. 
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Figure 4. Culture result on Sabouraud Dextrose agar (SDA) media taken from infected skin tissue, 
(A) Macroscopically indicates bright brown filament. (B) Microscopically shows brown Medlar 




/ verrucous dermatitis is a Geraniaceae-
induced fungal disease. Some fungus species 
belonging to dermaticeae are Phiaophora 
verrucosa, Fonseceae pedrosoi, Fonseceae 
compactum, Wangiella dermatitidis, 
Cladosporium carrionii and Rhinocladiella 
aquaspresa.1,8 This fungal group is dark 
brown to blackish-brown coloured and creates 
a filamentous colony. The fungi live on soil, 
wood, and decomposed plants. This infection 
occurs due to direct inoculation from fungi 
into the skin.1,6,7   
Chromoblastomycosis is found 
sporadically in South America and Central 
America, rarely in North America. It occurs in 
Caribbean, African, Australian, and Japanese 
areas. This infection often occurs, particularly 
in rural male workers. Most cases were 
reported in tropical and humid subtropical 
climate areas such as America, Asia, and 
Africa. The highest prevalence rate is reported 
in Mexico, Cuba. Venezuela, Colombia, and 
Brazil.8,9 Japan has the highest incidence rate 
among the Asian populations with a ratio of    
1: 416,000 people.3 In tropic and subtropic 
countries, it occurs more commonly in males 
aged 30-60 years working in the farming 
sector (about 70% of the cases) because they 
are risky of being injured by the part of the 
plant constituting the factor causing it. The 
incidence ratio of males to females is 1: 0.8 in 
Japan.10,11 It mostly affects the upper part of 
the body, buttock, limb, and particularly the 
leg, which most frequently has contact with 
the material containing fungi such as soil, 
plant, or decomposed wood.12 
The lesion is gradually expanding the 
papule and creates hyperkeratosis plaque.2,5,13 
Some of these plaque lesions are flat and 
spread gradually with scars around the lesion 
center. The initial lesion can be an ulcer. 
Then, some months or years later, large 
hyperkeratosis is created with about 2-3 cm 
thickness. A secondary ulcer may occur; this 
lesion usually gives pain unless secondary 
bacterial infection occurs. It can result in 
itchiness and pain. Hematogenous spread may 
rarely occur, and brain abscess has never been 
found.2,3,13,14 Secondary infection will finally 
result in lymphatic stasis that changes into 
elephantiasis. Some lesions can be 
psoriasiform lesions.15 Squamous cell 
carcinoma may occur in chronic lesions.16 
The most frequent form is verrucous lesion 
spreading gradually and locally.17 
Technically, chromoblastomycosis diagnosis 
does not result in big trouble, but the 
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diagnosis is chronic. Standardized diagnosis 
builds on the finding of Medlar body from the 
skin scraping, and microscopic culture or 
histopathology.2,3,17-20  
A similar complaint is found in this 
case, like a lump and itchiness on the patient’s 
left leg, having persisted for years. The lesion 
complained of is getting bigger and wider 
over time. The result of physical examination 
also confirms chromoblastomycosis 
presentation in which there are multiple 
hyperpigmented nodules with the verrucous 
surface. In addition to history taking and 
physical examination, chromoblastomycosis 
diagnosis can be established with a skin 
scraping examination using KOH 10% with 
oval or spherical spores, thick wall, and 
blackish-brown colour. The result of fungus 
culture using SDA media macroscopically 
shows bright brown filamentous colony and 
microscopically shows brownish Medlar 
body. The culture slide examination results 
show that long branching filamentous hypha 
with conidia is consistent with Fonsecaea 
pedrosoi. Similarly, histopathological 
examination with HE and PAS staining shows 
epidermal thickening (pseudo-
epitheliomatous hyperplasia), granulomatous 
inflammation, and Medlar body.  
Comparative diagnosis in this patient is 
squamous cell carcinoma (SCC).21 SCC is a 
malignant neoplasm resulting from epidermal 
suprabasal keratinocytes abnormality.22 
Generally, SCC often occurs in 40-50 years of 
age with the areas exposed more to sunlight 
like face, ears, lower lip, back, hand, and 
lower limb. The presentation of SCC includes 
easily bleeding reddish ulcerated nodule or 
verrucous plaque/papule indicating 
cornification and or hyperkeratosis signs. 
Histopathological examination showed SCC 
consists of irregular mass composing 
proliferating epidemic cells invading dermis. 
The well-differentiated SCC indicates fast 
keratinization on the squamous cellular layer. 
Tumour cells are focally and concentrically, 
followed by keratin mass, creating typical 
horn pearls on SCC. Comparative diagnosis 
of squamous cell carcinoma can be overridden 
from histopathological examination, finding 
no image of horn pearls and or malignancy 
cells.22,23 
Chromoblastomycosis treatment can be 
both physical and non-physical.11 Physical 
therapy can include standardized or excision 
surgery with margin and appropriate 
electrodesiccation curettage for the small and 
clearly-bordered lesion.24 Another physical 
therapy is local thermal therapy. It is based on 
fungi like F. pedrosoi, vulnerable to high 
temperatures. Using a hot chemical pouch for 
one month with a bandage on the lesion for 24 
hours per day results in the lesion 
improvement, while total resolution occurs on 
the second month. Cold therapy or 
cryotherapy is the best physical therapy, 
particularly when it is combined with 
systemic/chemotherapy anti-fungal agent 
because the disease spreading has been 
reported during the treatment with 
cryotherapy only.23,24 Cryotherapy uses liquid 
nitrogen, the coldest cryogenic agent with the 
largest freezing ability, to stimulate 
inflammatory reaction and necrosis on the 
affected tissue. Cryotherapy is recommended, 
particularly to the larger one (15 cm2). It 
should be conducted in different part and time 
intervals. According to the lesion width, the 
freezing time for cryotherapy using liquid 
nitrogen ranges between 30 seconds and 4 
minutes.23 In this case, cryotherapy is 
conducted with a freezing time of 1 (one) 
minute in one therapeutic cycle per week.  
In addition to enhancing physical 
therapy, chromoblastomycosis can also be 
treated using chemotherapy, including 5-
Flurocytosine (5FC), with the recommended 
dose ranging between 100 and 150 mg/kg/day 
divided into four doses for 6-12 months, and 
topical 5FC can also be used. Itraconazole can 
also be used with the recommended dose 
ranging between 200-400 mg/day dependent 
on lesion severity and therapy until 
improvement is achieved (3 months to 1 
year).11,23 The use of itraconazole in pulse 
dose regime (400 mg/day in a week for a 
month) has been succeeded in some cases.11 
Other drugs like Terbinafine with a dose of 
250-500 mg/day and flucytosine of 150-200 
mg/kg BW/day divided into four doses can 
                                          Jurnal Profesi Medika : Jurnal Kedokteran dan                             
ISSN 0216-3438 (Print). ISSN 2621-1122 (Online)                                                                                               Kesehatan 
 
Vol. 15 No 2 2021 DOI: http://dx.doi.org/10.33533/jpm.v15i2.2613                                                               224 
 
also be used.24  Other evidence explains that 
the use of Terbinafine 250 mg is more 
effective. Tiabendazole is another alternative, 
but it is not tolerable to patients due to its side 
effect on the gastrointestinal tract.23 
Therapy combination should be 
considered for patients with 
chromoblastomycosis. Surgery method can 
heal but on another side also make spreading 
the disease.11 Therefore, it is essential to apply 
additional chemotherapy, particularly 
itraconazole or Terbinafine. The combination 
of hot therapy and itraconazole can be a good 
choice, but cryotherapy along with 
itraconazole can be better, particularly on the 
wider lesion case. Itraconazole is applied until 
the maximum lesion reduction is achieved, 
occurring after 8-12 months of treatment, and 
then surgery can be done in sessions.11,23 
Combined oral itraconazole and frozen 
surgery therapy are administered to this 
patient. Itraconazole was administered at a 
dose of 400 mg/day for 1 (one) week (pulse 
dose) and then followed with resting for 3 
(three) weeks and can be conducted in some 
cycles. The administration of pulse dose is 
intended by giving large dose intermittently to 
improve therapeutic effect and to reduce the 
side effect. Frozen surgery or cryotherapy is 
administered in 1 (one) cycle for 60 seconds 
per week, constituting a good therapeutic 
option in chromoblastomycosis cases. 
The management of 
chromoblastomycosis can be monitored with 
clinical presentation, supported with 
examination on skin scraping with KOH 10%, 
and or histopathology. However, to find out 
whether the lesion, in this case, has been cured 
or is potentially recurrent. A repeated 
examination is required in the third or fourth 
month of therapy.23 In this case, the patient 
was followed monthly and got clinical 
improvement. KOH 10% examination on the 
third month found no spore or Medlar body 
appearance (Figure 8). 
 
CONCLUSION 
This case reported a 
chromoblastomycosis case in a male farmer, 
70 years old. The diagnosis is established 
based on history, physical examination, 
histopathological examination, and fungal 
culture examination. We found Medlar body / 
sclerotic body / round-or oval-shaped single 
and or colony copper penny with blackish-
brown thick wall. The patient was treated with 
combined therapy of oral itraconazole 400mg 
(pulse dose) and cryotherapy for three 
months, resulting in good clinical 
improvement. Chromoblastomycosis grows 
very slowly and is difficult to treat with a high 
recurrence rate, so early diagnosis is critical.      
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